Hanson & Doremus Investment Management Has $885,000 Stock Position in Integer Holdings Co. (NYSE:ITGR)

Hanson & Doremus Investment Management lowered its position in shares of Integer Holdings Co. (NYSE:ITGR) by 1.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 6,677 shares of the medical equipment provider’s stock after selling 71 shares during the quarter. Hanson & Doremus Investment Management’s holdings in Integer were worth $885,000 as of its most recent SEC filing.

Several other hedge funds have also made changes to their positions in the company. Contravisory Investment Management Inc. lifted its holdings in shares of Integer by 55.9% in the third quarter. Contravisory Investment Management Inc. now owns 223 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 80 shares in the last quarter. Huntington National Bank grew its holdings in shares of Integer by 8,933.3% during the third quarter. Huntington National Bank now owns 271 shares of the medical equipment provider’s stock valued at $35,000 after buying an additional 268 shares in the last quarter. R Squared Ltd acquired a new position in Integer during the fourth quarter valued at $44,000. Versant Capital Management Inc lifted its stake in Integer by 98.4% in the 4th quarter. Versant Capital Management Inc now owns 369 shares of the medical equipment provider’s stock worth $49,000 after acquiring an additional 183 shares in the last quarter. Finally, GAMMA Investing LLC boosted its position in Integer by 74.1% during the 3rd quarter. GAMMA Investing LLC now owns 653 shares of the medical equipment provider’s stock worth $85,000 after acquiring an additional 278 shares during the period. Hedge funds and other institutional investors own 99.29% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on ITGR shares. Citigroup upped their target price on Integer from $130.00 to $145.00 and gave the company a “neutral” rating in a report on Wednesday, December 11th. Wells Fargo & Company reiterated an “overweight” rating and issued a $160.00 target price on shares of Integer in a research report on Tuesday, December 3rd. Piper Sandler restated an “overweight” rating and set a $140.00 price target (up from $125.00) on shares of Integer in a report on Friday, October 25th. KeyCorp increased their price objective on Integer from $144.00 to $154.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. Finally, Benchmark boosted their target price on Integer from $130.00 to $140.00 and gave the company a “buy” rating in a research note on Monday, October 21st. One investment analyst has rated the stock with a hold rating and eight have given a buy rating to the company. According to data from MarketBeat.com, Integer currently has an average rating of “Moderate Buy” and a consensus price target of $146.56.

Integer Stock Performance

ITGR opened at $143.48 on Thursday. The stock has a 50-day moving average of $137.50 and a 200-day moving average of $130.17. The company has a debt-to-equity ratio of 0.67, a quick ratio of 2.09 and a current ratio of 3.28. Integer Holdings Co. has a 52-week low of $94.56 and a 52-week high of $145.66. The company has a market cap of $4.81 billion, a PE ratio of 44.28, a price-to-earnings-growth ratio of 1.80 and a beta of 1.12.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.